Armenta Ltd., an Agtech company, is developing innovative therapies to transform the standard of care for dairy cattle diseases. Our first target indication, mastitis, is a significant economic burden on dairy farms. It reduces milk yield and quality and increases culling rates, causing more than $2B in lost annual revenue in the U.S. and more than $1.5B in the E.U. Armenta aims to dramatically reduce the monetary losses from these pathologies, with the focus on a non-antibiotic mastitis therapy.
Location: Israel, Central, Ra‘anana
Employees: 11-50
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | CoLAB | colab.dfam... |
Mentions in press and media 1
| Date | Title | Description |
| 26.09.2019 | The land of alt milk and AI honey: notes from Israel’s AgriFood Week | I tucked into my first ever breakfast in Israel early this Sunday morning faced with a blatantly biblical reminder. On my hotel’s breakfast counter across from me stood an enormous, oozing slab of honeycomb — right next to a whirring milk d... |